Elevated serum-circulating RNA in patients with conventional renal cell cancer

Anticancer Research

Volumn 28, Issue 1 A, 2008, Pages 321-326

  Feng, Gang ^a   Li, Guorong ^a   Gentil Perret, Anne ^a   Tostain, Jacques ^a   Genin, Christian ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Circulating RNA; Diagnosis; Renal cancer; Serum

Indexed keywords

RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; ONCOCYTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 40549104113     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Sutphin PD, Chan DA, Li JM, Turcotte S, Krieg AJ and Giaccia AJ: Targeting the loss of the von Hippel-Lindau tumor suppressor gene in renal cell carcinoma cells. Cancer Res 67: 5896-5905, 2007.
2. Chan KCA and Lo YMD: Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. BJC 96: 681-685, 2007.
3. Swarup V and Rajeswari MR: Circulating (cell-free) nucleic acids - a promising, non-invasive tool for early detection of several human diseases. FEBS lett 581: 795-799, 2007.
4. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E and Wong DT: Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24: 1754-1760, 2006.
5. Lo YM, Tsui NB, Chiu RW, Lau TK, Leung TN, Heung MM, Gerovassili A, Jin Y, Nicolaides KH, Cantor CR and Ding C: Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nature Med 13: 218-223, 2007.
6. Bremnes RM, Sirera R and Camps C: Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 49: 1-12, 2005.
7. Sobin H and Wittekind CH (eds.). International Union Against Cancer, UICC, in TNM Classification of Malignant Tumors, 6th edition. New York, Wiley-Liss, 2002.
8. Fuhrman SA, Lasky LC and Limas C: Prognostic significance of morphologic parameters in renal cell carcinomas. Am J Surg Path 6: 665-663, 1982
9. Ziegler A, Zangemeister-Wittke U and Stahel RA: Circulating DNA: a new diagnostic gold mine? Cancer Treatment Reviews 28: 255-271, 2002.
10. Flamini E, Mercatali L, Nanni O, Calistri D, Nunziatini R, Zoli W, Rosetti P, Gardini N, Lattuneddu A, Verdecchia GM and Amadori D: Free DNA and carcinoembryonic antigen serum levels: an importatnt combination for diagnosis of colorectal cancer. Clin Cancer Res 12: 6985-6988, 2006.
11. Boddy JL, Gal S, Malone PR, Harris Al and Wainscoat JS: Prospective study of quantitative of plasma DNA levels in the diagnosis of malignant versus benign prostate disease. Clin Cancer Res 11: 1394-1399, 2005.
12. Sozzi G, Conte D, Mariani L, Lo Vullo S, Roz L, Lombardo C, Pierotti MA and Tavecchio L: Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61: 4675-4678, 2001.
13. Reddi K and Holland JF: Elevated serum ribonuclease in patients with pancreatic cancer. PNAS 73: 2305-2310, 1976.
14. Sheid B, Lu T, Pedrinan L, Nelson JH: Plasma ribonuclease: a marker for the detection of ovarian cancer. Cancer 39: 2204-2208, 1997.
15. Neuzillet Y, Lechevallier E, Andre M, Daniel L and Coulange C: Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0cm) renal masses. J Urol 171: 1802-1805, 2004.
16. Rykova EY, Wunsche W, Brizgunova OE, Skvortsova TE, Tamkovich SN, Senin IS, Laktionov PP, Sczakiel G and Vlassov VV: Concentration of circulating RNA from healthy donors and cancer patients estimated by different methods. Ann New York Acad Sci 1075: 328-333, 2006.
17. Garcia V, Garc£a JM, Peña C, Silva J, Domínguez G, Hurtado A, Alonso I, Rodriguez R, Provencio M and Bonilla F: Thymidylate synthase messenger RNA expression in plasma from patients with colon cancer: prognostic potential. Clin Cancer Res 12: 2095-2100, 2006.
18. Wong SC, Lo SF, Cheung MT, Ng KO, Tse CW, Lai BS, Lee KC and Lo YM: Quantification of plasma β-catenin mRNA in colorectal cancer and adenoma patients. Clin Cancer Res 10: 1613-1617, 2004.
19. Cheung ST, Liu CL, Chow JP, Lee YT, Ip YC, Ho JC and Fan ST: Preoperative plasma transcript AA454543 level is an independent prognostic factor for hepatocellular carcinoma after partial hepatectomy. Neoplasia 8: 696-701, 2005.
20. Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J and Shiota G: Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer. Cancer Sci 97: 1366-1373, 2006.
21. Kamm RC and Smith AG: Nucleic acid concentrations in normal human plasma. Clin Chem 18: 519-522, 1972.
22. Fleischhacker M: Biology of circulating mRNA, Still more questions than answers? Ann New York Acad Sci 1075: 40-49, 2006.
23. Wong BC, Chan KC, Chan AT, Leung SF, Chan LY, Chow KC and Lo YM: Reduced plasma RNA integrity in nasopharyngeal carcinoma patients. Clin Cancer Res 12: 2512-2516, 2006.